Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa.
Vaccination with a recombinant modified vaccinia Ankara expressing antigen 85A from Mycobacterium tuberculosis, MVA85A, induces high levels of cellular immune responses in UK volunteers. We assessed the safety and immunogenicity of this new vaccine in West African volunteers.We vaccinated 21 healthy...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2008-08-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2488375?pdf=render |